These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31570392)
21. Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Furi L; Ciusa ML; Knight D; Di Lorenzo V; Tocci N; Cirasola D; Aragones L; Coelho JR; Freitas AT; Marchi E; Moce L; Visa P; Northwood JB; Viti C; Borghi E; Orefici G; ; Morrissey I; Oggioni MR Antimicrob Agents Chemother; 2013 Aug; 57(8):3488-97. PubMed ID: 23669380 [TBL] [Abstract][Full Text] [Related]
22. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. Stickler DJ Symp Ser Soc Appl Microbiol; 2002; (31):163S-170S. PubMed ID: 12481841 [TBL] [Abstract][Full Text] [Related]
23. Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii - A first report from the Kingdom of Saudi Arabia. Vijayakumar R; Sandle T; Al-Aboody MS; AlFonaisan MK; Alturaiki W; Mickymaray S; Premanathan M; Alsagaby SA J Infect Public Health; 2018; 11(6):812-816. PubMed ID: 29907439 [TBL] [Abstract][Full Text] [Related]
24. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. Stickler DJ J Appl Microbiol; 2002; 92 Suppl():163S-70S. PubMed ID: 12000625 [TBL] [Abstract][Full Text] [Related]
25. Biocide susceptibilities and biofilm-forming capacities of Acinetobacter baumannii clinical isolates from Malaysia. Nor A'shimi MH; Alattraqchi AG; Mohd Rani F; A Rahman NI; Ismail S; Abdullah FH; Othman N; Cleary DW; Clarke SC; Yeo CC J Infect Dev Ctries; 2019 Jul; 13(7):626-633. PubMed ID: 32065820 [TBL] [Abstract][Full Text] [Related]
26. Single-disk diffusion testing (Kirby-Bauer) of susceptibility of Proteus mirabilis to chloramphenicol: significance of the intermediate category. Furtado GL; Medeiros AA J Clin Microbiol; 1980 Oct; 12(4):550-3. PubMed ID: 6999022 [TBL] [Abstract][Full Text] [Related]
27. Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacΔE and qacE efflux pump genes and antibiotic resistance. Abuzaid A; Hamouda A; Amyes SG J Hosp Infect; 2012 Jun; 81(2):87-91. PubMed ID: 22498639 [TBL] [Abstract][Full Text] [Related]
28. DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis. Weigel LM; Anderson GJ; Tenover FC Antimicrob Agents Chemother; 2002 Aug; 46(8):2582-7. PubMed ID: 12121936 [TBL] [Abstract][Full Text] [Related]
29. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. Luzzaro F; Perilli M; Amicosante G; Lombardi G; Belloni R; Zollo A; Bianchi C; Toniolo A Int J Antimicrob Agents; 2001 Feb; 17(2):131-5. PubMed ID: 11165117 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of resistance genes to biocides in antibiotic-resistant Pseudomonas aeruginosa clinical isolates. Namaki M; Habibzadeh S; Vaez H; Arzanlou M; Safarirad S; Bazghandi SA; Sahebkar A; Khademi F Mol Biol Rep; 2022 Mar; 49(3):2149-2155. PubMed ID: 34854015 [TBL] [Abstract][Full Text] [Related]
31. Recently introduced qacA/B genes in Staphylococcus epidermidis do not increase chlorhexidine MIC/MBC. Skovgaard S; Larsen MH; Nielsen LN; Skov RL; Wong C; Westh H; Ingmer H J Antimicrob Chemother; 2013 Oct; 68(10):2226-33. PubMed ID: 23739538 [TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs. Valentine BK; Dew W; Yu A; Weese JS Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial Susceptibility and Molecular Epidemiology of Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL; BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738 [TBL] [Abstract][Full Text] [Related]
36. Effect of povidone-iodine and propanol-based mecetronium ethyl sulphate on antimicrobial resistance and virulence in Staphylococcus aureus. Barakat NA; Rasmy SA; Hosny AEMS; Kashef MT Antimicrob Resist Infect Control; 2022 Nov; 11(1):139. PubMed ID: 36369050 [TBL] [Abstract][Full Text] [Related]
37. Phenotypic ESBL and non-phenotypic ESBL isolates of Klebsiella pneumoniae exhibit differing responses to induced antimicrobials resistance and subsequent antibiotic cross-resistance. Haddadin RN; Collier PJ; Haddadin S J Appl Microbiol; 2023 Feb; 134(2):. PubMed ID: 36724268 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of biocide resistance genes and chlorhexidine and mupirocin non-susceptibility in Portuguese hospitals during a 31-year period (1985-2016). Conceição T; de Lencastre H; Aires-de-Sousa M J Glob Antimicrob Resist; 2021 Mar; 24():169-174. PubMed ID: 33373736 [TBL] [Abstract][Full Text] [Related]
39. The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms. Kwiecińska-Piróg J; Skowron K; Zniszczol K; Gospodarek E Biomed Res Int; 2013; 2013():930876. PubMed ID: 24151628 [TBL] [Abstract][Full Text] [Related]